FARO ECONÓMICOSTOCK ANALYSIS

SMMT — analysis and forecast

$15.27-8.2% todaySummit Therapeutics Inc.
Verdict
Neutral
RSI (14)
49
MACD
▲ rising
Trend
Downtrend
Volatility
78%
52w range
20%

🧬 Faro multibagger DNA

Does it look today like the big multibaggers (×10, ×100) did when they started? 7 traits measured with public data.

44/ 100
Weak

Strongest: Balance sheet and Room to grow. Most lacking: Business quality and Cash it generates.

Room to grow75

Worth $12.2 B. To grow ×10 it would have to reach $122 B.

Sales engine35

Not enough sales data.

Business quality0

Gross margin 0%, operating margin 0%, return on equity -220%.

Cash it generates19

Free cash flow −$214 M a year = -1.8% of its value (burning cash).

Price vs. growth40

Trades at —× sales with no growth to back it.

Balance sheet90

Net cash equal to 5% of its value.

Faro seal65

No recent federal contracts on the radar · inside a Faro megatrend · insiders own 80.7%.

⏱️ Timing (not scored): near its 12-month low · below its 200-day average · trailing the S&P 500 by 22 points over 12 months.

Built on the traits of 365 stocks that went ×100 (Mayer, 1962–2014) and 464 that went ×10 (Yartseva, 2009–2024), plus the Faro thesis. It does not predict the price and is not a recommendation. How it works and the ranking →

🔢 What the numbers say

The last 12 months, in plain words

🗓️ Forecast by horizon

Directional bias · probability of rising · expected price and likely range (68%)

HorizonBiasProb. upExpected price68% range
1 dayNeutral51%$15.26 -0.1%$14.53 – $16.03
3 daysNeutral51%$15.24 -0.2%$14.00 – $16.59
1 weekNeutral50%$15.22 -0.3%$13.64 – $16.99
15 daysNeutral50%$15.18 -0.6%$12.99 – $17.73
1 monthNeutral48%$15.07 -1.3%$12.04 – $18.88
3 monthsNeutral44%$14.69 -3.8%$9.95 – $21.69

Recent momentum: -0.7% over 20 days · +16.5% over 60 days. The further out the horizon, the wider and more uncertain the forecast.

📈 Probability cone

📜 Government contracts

We have no notable federal contract on file for SMMT. You can look it up yourself at USASpending.gov or in the Government Sources hub.

📚 Go deeper: Faro Library reports

PDF reports built from official filings. Your first one is free, no email; then $1.99 each or all 34 for $25 — included in Navigator and Admiral.

See all 34 reports →

❓ Frequently asked questions about SMMT

Could SMMT be the next NVIDIA?

Its Faro multibagger DNA is 44/100 (weak): it measures how much it looks today like the big multibaggers did when they started (size, sales growth, quality, cash, price versus growth, balance sheet and public contracts). To grow ×10 it would need to be worth about 10 times today's value. Not a prediction or a recommendation.

How much has SMMT fallen in the last year?

Summit Therapeutics (SMMT) is down 20.3% over the last 12 months and trades at $15.27, 42.1% below its 52-week high ($26.38). 52-week range: $12.43 – $26.38.

How volatile is SMMT stock?

Its annualized volatility is around 78% and its worst drop from a peak over the last year was 52.9%. For reference, the S&P 500 usually moves 15–20% a year.

Does SMMT have U.S. government contracts?

There is no notable federal contract in Faro's register. You can search USASpending.gov.

Is now a good time to buy SMMT?

Nobody can know that for sure and this page is not a buy recommendation. What the data shows today: neutral technical bias, RSI 49, price below its 50-day average and an estimated 48% probability of being higher in 1 month. Use it as a starting point for research, not as a signal.

🧠 How it is calculated

The verdict combines trend (20/50/200 moving averages), momentum (RSI, MACD), mean reversion (Bollinger Bands), conviction (volume) and historical drift, weighted differently for each horizon. Uncertainty is modeled with a lognormal probability cone (geometric Brownian motion). This is statistical analysis, not a crystal ball.

🔦 Keep analyzing

Other stocks Faro watches

🔮 Oracle Pro 📈 Trading Room 📅 Calendar

⚠️ Educational tool. Not financial advice. Forecasts are statistical estimates based on historical volatility; the market can do the opposite. Data via Yahoo Finance. Always verify before trading. The decisions are yours.